DNA TOPOISOMERASES AND OTHER ENZYMES AFFECTING CHROMATIN

DNA 拓扑异构酶和其他影响染色质的酶

基本信息

  • 批准号:
    3275504
  • 负责人:
  • 金额:
    $ 12.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1980
  • 资助国家:
    美国
  • 起止时间:
    1980-07-01 至 1991-06-30
  • 项目状态:
    已结题

项目摘要

A major aim is to continue studies on the in vivo roles of eukaryotic DNA topoisomerases using yeast topoisomerase mutants and genes isolated previously. Five separate projects are proposed: 1) to determine the role of topoisomerases in ribosomal RNA synthesis, 2) to learn why overproduction of DNA topoisomerase II is deleterious to yeast, 3) to clone human topoisomerase I and II genes by direct selection in yeast. A human cDNA library will be placed in a yeast expression vector plasmid. The DNA will be used to transform a yeast mutant deficient in topoisomerase I and II; rare transformants which have gained topoisomerase I or II activity will be selected by their more rapid growth. DNA topoisomerases are known to be the targets of a wide variety of anti-cancer drugs. Isolation of their genes will allow overproduction of the enzymes, which will be useful for testing new derivatives of the known drugs, 4) to determine if the in vivo target of the drug novobiocin in yeast is topoisomerase II or some other enzyme, and 5) to determine if RNA polymerase II, the enzyme responsible for mRNA synthesis, has topoisomerase activity inherent in it, distinct from the known topoisomerases I and II. Another major aim is to find a yeast mutant deficient in histone acetyl transferase and to use the mutant to determine the role of histone acetylation in chromatin structure and function. The approach will be the same as was used successfully to identify yeast topoisomerase mutants, namely, to screen a collection of heavily mutagenized temperature-sensitive mutants by direct enzymatic assay. Once a mutant is identified, its phenotypes will be studied to learn about the in vivo role of the enzyme.
一个主要的目标是继续研究真核生物DNA在体内的作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rolf Sternglanz其他文献

Rolf Sternglanz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rolf Sternglanz', 18)}}的其他基金

Histone Modifying Enzymes and Transcription
组蛋白修饰酶和转录
  • 批准号:
    7898288
  • 财政年份:
    2009
  • 资助金额:
    $ 12.79万
  • 项目类别:
YEAST HISTONE ACETYLATION GENES AND MUTANTS
酵母组蛋白乙酰化基因和突变体
  • 批准号:
    6180701
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
Histone Modifying Enzymes and Transcription
组蛋白修饰酶和转录
  • 批准号:
    7244367
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
Yeast Histone Acetylases and Sir2-like Deacetylases
酵母组蛋白乙酰化酶和 Sir2 样脱乙酰酶
  • 批准号:
    6636230
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
Yeast Histone Acetylases and Sir2-like Deacetylases
酵母组蛋白乙酰化酶和 Sir2 样脱乙酰酶
  • 批准号:
    6331573
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
Histone Modifying Enzymes and Transcription
组蛋白修饰酶和转录
  • 批准号:
    6989151
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
YEAST HISTONE ACETYLATION GENES AND MUTANTS
酵母组蛋白乙酰化基因和突变体
  • 批准号:
    2701819
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
YEAST HISTONE ACETYLATION GENES AND MUTANTS
酵母组蛋白乙酰化基因和突变体
  • 批准号:
    2024195
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
Yeast Histone Acetylases and Sir2-like Deacetylases
酵母组蛋白乙酰化酶和 Sir2 样脱乙酰酶
  • 批准号:
    6730531
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:
Yeast Histone Acetylases and Sir2-like Deacetylases
酵母组蛋白乙酰化酶和 Sir2 样脱乙酰酶
  • 批准号:
    6519808
  • 财政年份:
    1997
  • 资助金额:
    $ 12.79万
  • 项目类别:

相似海外基金

DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 12.79万
  • 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
  • 批准号:
    2338236
  • 财政年份:
    2024
  • 资助金额:
    $ 12.79万
  • 项目类别:
    Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
  • 批准号:
    23K07078
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
  • 批准号:
    23H05475
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
DNA Repair State Machines
DNA 修复状态机
  • 批准号:
    EP/X027406/1
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
    Research Grant
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
  • 批准号:
    2246561
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
    Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
  • 批准号:
    10666307
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
  • 批准号:
    10651048
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
  • 批准号:
    10734425
  • 财政年份:
    2023
  • 资助金额:
    $ 12.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了